Category Archives: Uncategorized

Behavioral Health Group (BHG) is continuing its commitment of providing high quality treatment for opioid addiction in the state of Alabama with the addition of the BHG Cullman Treatment Center. BHG now operates five addiction treatment centers in Alabama and is one of the leading treatment providers in the state. “We are grateful for the opportunity to increase our role in providing high quality care for opioid-use disorder to the community of Cullman and across the entire state of Alabama,” said Dwight Mussleman, Chief Development Officer of BHG.

While the Cullman Treatment Center is the most recent addition to the BHG treatment center network, BHG has added four other locations in the state within the past year. BHG’s first Alabama treatment center was in Tuscaloosa in November of 2017. Since then, BHG has acquired locations in Sheffield, Bessemer, Gadsden and now Cullman. “Opioid-use disorder continues to afflict communities across the country, including those of Alabama. While this public health crisis presents significant challenges, we at BHG know that opioid addiction is treatable. Through evidence-based programs such as Medication Assisted Treatment, along with counseling, successful recovery is possible,” said Jay Higham, CEO of BHG.

Along with counseling, BHG offers Medication Assisted Treatment (MAT), the gold standard of care for opioid addiction. MAT utilizes the combination of FDA approved medication with counseling and other support service for a comprehensive treatment approach to addiction. Dr. Chris Marshall, National Medical director for BHG, talks about the importance of this comprehensive approach, “The U.S. has almost lost an entire generation in the workforce. Studies consistently show that Medication Assisted Treatment and counseling decrease illicit opioid use, improve overall health and get people back to their normal lives.”

The BHG Cullman Treatment Center is located at 1912 Commerce Avenue Northwest, Cullman, AL, and is now accepting new patients. Additionally, BHG Cullman Treatment Center will be joining the four other BHG Alabama locations in accepting Medicaid effective January 2019. For more information please visit bhgrecovery.com or call 844-535-7291.


BHG Alabama Locations:

BHG Bessemer Treatment Center
4204 Edmonton Dr, Bessemer, AL 35022

BHG Cullman Treatment Center
1912 Commerce Ave NW, Cullman, AL 35055

BHG Gadsden Treatment Center
1121 Gardner Street, Gadsden, AL 35901

BHG Shoals Treatment Center
3430 North Jackson Highway, Sheffield, AL 35660

BHG Tuscaloosa Treatment Center
1001 Mimosa Park Rd, Tuscaloosa, AL 35405


For Business Development Information:
Dwight Mussleman
Dwight.Mussleman@bhgrecovery.com
214-365-6114

Media Contact:
Joshua Wright
Joshua.wright@bhgrecovery.com
214-365-6146

BHG Nashville Counselor Supervisor, Annie Battley, recently participated as a panelist at the Medication Assisted Treatment Conference hosted by the Tennessee Department of Mental Health and Substance Abuse on September 24, 2018. Speaking on the Combined Learning Panel, Annie fielded questions by attendees and discussed the importance of integrated care for patients struggling with substance abuse issues. Other important topics discussed by the panel included education about the role of counseling and support services within medication-assisted treatment as well as the need to continue efforts in destigmatizing addiction by recognizing addiction as a disease that can be treated rather than a moral failure. Fellow panelist included Stephen Loyd, M.D. and Erica Schlesinger, PharmD. The panel was moderated by Paul Fuchar, Executive Director for CADAS.

Speaking about her experience on the panel, Annie said, “It was an honor to be sitting alongside so many distinguished people in the addiction and MAT community. I believe the audience, myself included, walked away with a better understanding of the importance of integrated care for the addiction population.” Annie represented BHG well and we are grateful that she was able to contribute to this important dialogue.

For more information about Medication Assisted Treatment and services offered by BHG please visit https://bhgrecovery.com/treatment-services/.

Behavioral Health Group (BHG) is increasing its presence in Virginia with the addition of BHG Franklin Treatment Center.  With existing treatment centers located in Chesapeake, Newport News and Virginia Beach, BHG Franklin represents the fourth opioid addiction treatment center in the state for BHG. “Our mission is to expand access to evidence-based treatment for addiction to the underserved areas in the state. The addition of BHG Franklin is a key part of that effort and provides an opportunity to build on the great work that has already been started by the team here,” said Dwight Mussleman, Chief Development Officer for BHG.

As the opioid crisis continues to ravage the communities of Virginia, there is a critical need for access to proven treatment. BHG offers medication-assisted treatment, a combination of FDA approved medication and counseling that has become known as the “gold standard” of care for treatment of opioid addiction. “Research shows that medication-assisted treatment and counseling decrease illicit opioid use, improve overall health and get people back to their normal lives. We must focus on treatment for the people and families currently struggling with this problem, as well as prevention,” said Dr. Christopher Marshall, National Medical Director for BHG.

The Behavioral Health Group Franklin Treatment Center is located at 1333 Carrsville Highway, Franklin, VA, and is now accepting new patients. In addition to self-pay plans, BHG Franklin also accepts Anthem Medicaid. For more information please visit franklin.bhgrecovery.com or call 757-304-9857.

About Behavioral Health Group:

Behavioral Health Group (BHG) is a leading outpatient opioid addiction treatment provider with the understanding that opioid use disorder is a chronic brain disease, not a moral failure. BHG offers medication-assisted treatment which utilizes a combination of FDA approved medications along with counseling and behavioral interventions to treat opioid addiction. In addressing both the physical and psychosocial aspects of addiction, patients are given the best opportunity for a successful recovery. With 50 treatment locations across 11 states, BHG provides services to thousands of individuals and their communities. BHG Treatment Centers are accredited by The Joint Commission.

For Business Development Information:
Dwight Mussleman
Dwight.Mussleman@bhgrecovery.com
214-365-6114

Media Contact:
Joshua Wright
Joshua.wright@bhgrecovery.com
214-365-6146

Seeing a friend or family member struggle with opioid addiction is an extremely difficult and frustrating experience. It my create feelings of helplessness, heartbreak and anger. Despite your best efforts, it may feel like nothing you do helps. Setting boundaries and deciding how far to extend oneself can be difficult and is a personal decision for each individual to make. However, one thing that we should always do is keep in mind that opioid addiction is a brain disease, not a moral failure. Understanding this allows us to deal with the situation for what it is, a complex medical issue with mental, physical and social components. This is why, as frustrating as it may be, a loved one is unlikely to be able to stop using opioids on their own through sheer willpower. Opioids effect brain chemistry by blocking pain signals and flooding the reward system of the brain with dopamine. The absence of these opioids in the system can cause severe withdrawal symptoms. Over time, individuals may develop a tolerance and need more and more opioids just to feel normal. You can learn more about how opioids work and why they are so hard to quit here.

The good news is that there is hope for your loved one in the form of proven treatment for opioid addiction. Through Medication-Assisted Treatment individuals have the opportunity to take their lives back from opioids. Medication-Assisted Treatment (MAT) utilizes medications in combination with counseling services to provide a comprehensive treatment program. In fact, research shows that Medication-Assisted Treatment is the most effective form of treatment for opioid use disorder.

Equipped with the knowledge that opioid addiction is a brain disease, not a moral failure, we are able to view addiction with more empathy and more realistic expectations about treatment needs. While the choice to seek help and stick with a recovery program is ultimately up to the individual, if you want to encourage a loved one to seek treatment, suggest they consider a program that offers Medication-Assisted Treatment as an option. With over 40 locations across 11 states, there may be a BHG treatment center near you. If so, give us a call at 844-535-7291 and we would be happy to discuss our treatment options with you or your loved one. You can also visit our Treatment Services page to learn more about our treatment programs.

Behavioral Health Group (BHG) is pleased to announce the opening of a new treatment facility in Berea, Kentucky. The new BHG Berea Treatment Center is located at 1000 Ace Drive, Berea, KY 40403. “With our seventh location in the state, we are increasing our commitment to tackling the opioid crisis in Kentucky and we are looking forward to continuing to serve the communities of Madison County with this new location,” said Dwight Mussleman, Chief Development Officer of BHG.
As part of a comprehensive approach to opioid addiction treatment, the services offered at BHG Berea include physician exams, counseling, medication dosing and lab testing. “Studies consistently show that medication-assisted treatment and counseling decrease illicit opioid use, improve overall health and get people back to their normal lives,” said Dr. Chris Marshall, National Medical Director of BHG. “We must now focus on treatment for the people and families currently struggling with this problem, as well as prevention. Behavioral Health Group is leading the way to get people the help they need with a time tested and structured program that helps people get their lives back.”
BHG will be hosting an open house on July 13 from 10 a.m. to 2 p.m. for community members to come and get a first-hand look at the treatment center, meet the treatment team and learn more about the services that BHG provides.

About Behavioral Health Group
Behavioral Health Group (BHG) is a leading outpatient opioid addiction treatment provider with the understanding that opioid use disorder is a chronic brain disease, not a moral failure. BHG offers medication-assisted treatment which utilizes a combination of FDA approved medications along with counseling and behavioral interventions to treat opioid addiction. In addressing both the physical and psychosocial aspects of addiction, patients are given the best opportunity for a successful recovery. With 48 treatment locations across 11 states, BHG provides services to thousands of individuals and their communities. BHG Treatment Centers are accredited by The Joint Commission.

If you or someone you know is looking for help with opioid addiction, please call at 844-535-7291, or visit bhgrecovery.com.

For Business Development Information:
Dwight Mussleman
Dwight.Mussleman@bhgrecovery.com
214-365-6114

Media Contact:
Joshua Wright
Joshua.wright@bhgrecovery.com
214-365-6146

BHG Acquires Third Location in Virginia with Newport News Treatment Center

Behavioral Health Group (BHG) recently completed the latest acquisition of a treatment center in Newport News, VA. BHG Newport News now represents the third location for the company in the state of Virginia. “We are very committed to serving the community in Southeast Virginia and we look forward to building on the great team already in place here,” said Dwight Mussleman, Chief Development Officer for BHG.

Virginia continues to struggle with an unmet need and demand for proven opioid addiction treatment services. BHG will immediately work to leverage its resources and operational experience to expand services and access to medication-assisted treatment, the gold standard for opioid use disorder treatment. “Opioid overdose related deaths continue to rise throughout the United States despite a decrease in the amount of prescriptions written for these substances. Heroin and illicit Fentanyl are becoming catastrophic problems,” Said Dr. Christopher Marshall, National Medical Director for BHG. “Behavioral Health Group is leading the way to get people the help they need with a time tested and structured program that helps people get their lives back.”

About BHG

Behavioral Health Group (BHG) is a leading outpatient opioid addiction treatment provider. Understanding that opioid use disorder is a chronic brain disease, not a moral failure, BHG offers Medication-Assisted Treatment which utilizes a combination of FDA approved medications along with counseling and behavioral interventions to treat opioid addiction. In addressing both the physical and psychosocial aspects of addiction, patients are given the best opportunity for a successful recovery.

BHG Treatment Centers are accredited by The Joint Commission.

For Business Development Information:
Dwight Mussleman
Dwight.Mussleman@bhgrecovery.com
214-365-6114

Media Contact:
Joshua Wright
Joshua.wright@bhgrecovery.com
214-365-6146

Increasing the accessibility of opioid addiction treatment is a primary commitment of Behavioral Health Group (BHG). In support of that effort, BHG is excited to announce we are now accepting certain types of health insurance in Tennessee. Many individuals are not aware that they may have substance abuse coverage as part of their plan. With insurance through your employer, or if you have a private policy, you may have coverage that could significantly reduce your out-of-pocket cost for treatment. Give BHG a call today to verify your benefits or to schedule an intake consultation and learn how your insurance can best work for you.

About BHG:

Behavioral Health Group (BHG) is a leading outpatient opioid addiction treatment provider. Understanding that opioid use disorder is a chronic brain disease, not a moral failure, BHG’s team of physicians, medical professionals and counselors provide comprehensive treatment to help patients take their lives back. BHG offers Medication-Assisted Treatment which utilizes a combination of FDA approved medications along with counseling and behavioral interventions to treat opioid addiction. In addressing both the physical and psychosocial aspects of addiction, patients are given the best opportunity for a successful recovery. BHG is privileged to serve Tennessee with treatment centers in Columbia, Dyersburg, Jackson, Knoxville, Memphis, Nashville and Paris. BHG Treatment Centers are accredited by The Joint Commission.

The Greater West Plains Area Chamber of Commerce has recognized BHG West Plains Treatment Center as “Business of the Week.” Program Director, Tess Miley, pointed to an increase in employment and decrease in criminal activity by BHG patients as just a few examples of the positive impact that BHG is having on the community and the lives of their patients. “BHG provides evidence-based, team-delivered, Medication-Assisted Treatment of opioid dependence allowing each patient to work toward achieving his or her best level of functioning in the community,” Miley said. Medication-Assisted Treatment (MAT) utilizes a combination of medication, such as methadone or Suboxone, along with counseling to provide comprehensive treatment for opioid-use disorder. Services provided by BHG West Plains are delivered in an outpatient setting. This allows patients to maintain productive lives within their families, jobs and communities.

Across the country, many communities and individuals do not have access to MAT, the gold-standard for opioid addiction treatment. Fortunately, in West Plains, Missouri, that is not the case. Tess Miley, Dr. Michael Stevenson and the entire BHG West Plains treatment team are proud to serve the West Plains community with high quality care for individuals struggling with opioid addiction.  You can learn more about the services provided by BHG West Plains at https://westplains-mo.bhgrecovery.com/, or call 417-257-1833.

View the original article from West Plains Daily Quill here.

While there is still much work to be done in combating America’s opioid epidemic, it is important to recognize where progress has been made. A recent report by the IQVIA INSTITUTE shows that the prescribing of opioids for pain management declined by nearly 8% in 2017. In fact, opioid prescriptions have been declining since they peaked in 2011. Additionally, those who are receiving opioid prescriptions are being prescribed lower dosages and for shorter periods of time than in previous years. Along with an increase in the general awareness of the risk for opioid misuse, the report points out that 24 states have set strict limits on the length and dosage of new opioid prescriptions. It appears that messaging and new guidelines related to the risk of opioid dependence are having a real impact on the prescribing habits of doctors.

At the same time that new opioid prescriptions are declining, Medication-Assisted Treatment (MAT) participation has seen a significant increase. MAT includes the administration of FDA approved medications along with support services, such as counseling, for a comprehensive approach to treatment. This form of treatment is considered the gold standard of care for opioid use disorder. Since the start of 2016, new prescriptions for the purpose of MAT have nearly doubled. IQVIA’s report credits the rise in new MAT starts, in part, to increased funding for MAT programs.

These trends are certainly encouraging. However, plenty of challenges remain before the tide is likely to turn in our country’s struggle with opioid addiction. The prevalence of opioid prescriptions is still extremely high when compared to historical levels or with other countries. Moreover, despite a recent spike in MAT participation, the vast majority of individuals struggling with opioid addiction are still not receiving the comprehensive care they need.

View the original IQVIA report here: https://www.iqvia.com/institute/reports/medicine-use-and-spending-in-the-us-review-of-2017-outlook-to-2022

Behavioral Health Group (BHG) is committed to removing barriers to treatment and providing the best possible care for those struggling with opioid addiction.  We understand that opioid addiction is a chronic brain disease, not a moral failure. BHG provides comprehensive treatment for opioid addiction with over 40 locations across 11 states. We are especially excited for the opportunity to participate in grant programs at our Louisiana, Alabama, North Carolina and Kansas treatment centers. These grant programs allow qualified individuals to receive treatment at no cost.

As the opioid epidemic continues to grow at an alarming rate in America, we are beginning to better understand the role that opioid prescriptions play in contributing to this problem. A recent article from the British Medical Journal titled “Postsurgical prescriptions for opioid naïve patients and association with overdose and misuse: retrospective cohort study” highlights an important issue facing doctors and patients today. This study shows a clear correlation between the length of time a person was prescribed opioids and the likelihood of misuse.

The research outcomes demonstrates that each additional week of prescribed opioid use post-discharge was associated with a 34.2% increase in the rate of misuse. This did not seem to follow the same risk related to the dose. The actual dose prescribed only became important with extended use. My conclusions from this point toward my continued opinion that surgeons and dentist should be very conservative in their postoperative prescribing as there is clear evidence pointing to significant risk of opioid misuse and addiction with prolonged prescriptions.

This study adds to the growing research  that for  for most general procedures surgeons should try to limit prescriptions to one week or less after the procedure or discharge and then provide no more than 1 additional week of post-operative opioid medications without extenuating circumstances. This should help limit new cases of opioid addiction developing and strengthen the push to more non-narcotic methods of pain relief.

Behavioral Health Group (BHG) is a leading provider of opioid addiction treatment services in Louisiana and nationwide. BHG is pleased to have recently completed their relocation from South Johnson Street to 2235 Poydras Street, Suite B, New Orleans, Louisiana 70119. With expanded dosing windows, more counseling offices and multiple waiting rooms, the new location has been fully renovated and optimized for the best possible patient experience. “The new BHG Downtown New Orleans location is one of the largest sites in the network of BHG treatment centers and is currently serving many individuals and families from Orleans Parish and beyond. With a new state of the art medical facility and a top notch clinical staff, patients receive the highest quality care when enrolled in treatment, as well as access to other services through community collaboration and referrals,” said Amanda Karistai, Regional Director of BHG.

The new facility adds over 2,000 square feet of space and provides substantial room for growth by more than doubling the potential patient capacity. This increased capacity for treatment couldn’t come too soon for a community and state that has been hit hard by the opioid crisis. From 2012 to 2016, heroin overdose deaths increased from 51 to 149 deaths and synthetic opioid-related deaths increased from 19 to 89 annually in Louisiana alone (NIDA, 2018). “Substance use disorder has rapidly become one of New Orleans’ most significant issues – one that must be addressed immediately and quickly. Medication-assisted treatment is evidence-based and the gold standard of treatment for individuals addicted to opiates. Through the services provided at Behavioral Health Group, individuals receive medical assessments and referrals, engage in counseling services, and are provided the tools necessary to become stable and resume normal living, all while decreasing the risk associated with illegal opiates,” said Dr. Daniel Bouchette, Medical Director for BHG Downtown New Orleans. “BHG welcomes individuals in all stages of life and guarantees patient-centered care. We are proud to have increased access to treatment in this area with the expansion of our Downtown New Orleans location.”

The team at BHG is paving the way for high quality treatment for individuals addicted to opioids, reflected in the organization’s recent development and investment in the greater New Orleans area. For more information about the treatment services provided at BHG Downtown New Orleans call 504-524-7205, or visit https://new-orleans-downtown.bhgrecovery.com/.

Media Contact:
Joshua Wright
Joshua.wright@bhgrecovery.com
214-365-6146

For Business Development Information:
Dwight Mussleman
Dwight.Mussleman@bhgrecovery.com
214-365-6114

 

Behavioral Health Group Launches Second Opioid Addiction Treatment Center in Springfield, Missouri

Responding to the continued public health crisis of opioid addiction, Behavioral Health Group, LLC (BHG) announced today the opening of an addiction treatment center in Springfield, Missouri.

Drug overdose deaths in the United States exceeded 52,000 in 2015 and now claim more lives than automobile accidents.  The majority of those deaths are a result of opioid drugs including prescription pain medication and heroin.

“Opioid addiction continues to ravage communities across the United States,” said Jay Higham, Chief Executive Officer of BHG. “Our Company’s mission is to expand access to evidence-based treatment in underserved markets across the United States.  With this new location, BHG now operates two full service opioid addiction treatment centers in the greater Springfield area and eight in all of Missouri.”

BHG adheres to a multidisciplinary approach to addiction treatment, which includes the use of medications indicated for opioid addiction treatment, including Methadone, Suboxone and buprenorphine maintenance therapy, to treat the biochemical aspect of addiction along with counseling to address psychosocial influences.  The Company’s approach to treatment is individualized under physician supervision in an outpatient setting.  Early in treatment patients visit the treatment center daily to receive medication and counseling.  As treatment progresses and the patient achieves greater medical and psychosocial stability the frequency of visits to the treatment center are reduced.

“The first 90 days are critical,” said Dr. Mark Carlson, Medical Director of Springfield and North Springfield Treatment Centers.  “During that time we work hard to ensure the patient is responding well to the medication and improving in their lives.  For patients in treatment for 90 days, we have excellent results as measured by almost all objective criteria – abstinence from drug use, improvements in employment, family dynamics and general well-being.”

In Missouri, BHG Treatment Centers are working to participate with most major medical insurance programs that cover addiction treatment.  The Company’s objective is to improve access to treatment for those struggling with addiction and recognizes that participating with third party payers is an important component of that objective.

View the original article here.

Behavioral Health Group Launches Opioid Addiction Treatment Center in Centennial, CO

Responding to the continued public health crisis of opioid addiction, Behavioral Health Group, LLC (BHG) announced today the opening of an addiction treatment center in Centennial, Colorado.

Drug overdose deaths in the United States exceeded 52,000 in 2015 and now claim more lives than automobile accidents.  The majority of those deaths are a result of opioid drugs including prescription pain medication and heroin.

“Opioid addiction continues to ravage communities across the United States,” said Jay Higham, Chief Executive Officer of BHG. “Our Company’s mission is to expand access to evidence-based treatment in underserved markets across the United States.  With this new location, BHG now operates five full service opioid addiction treatment centers in the greater Denver area – Downtown Denver, Westminster, Longmont, Fort Collins and Centennial.”

BHG adheres to a multidisciplinary approach to addiction treatment, which includes the use of medications indicated for opioid addiction treatment, including Suboxone and buprenorphine maintenance therapy, to treat the biochemical aspect of addiction along with counseling to address psychosocial influences.  The Company’s approach to treatment is individualized under physician supervision in an outpatient setting.  Early in treatment patients visit the treatment center daily to receive medication and counseling.  As treatment progresses and the patient achieves greater medical and psychosocial stability the frequency of visits to the treatment center are reduced.

“The first 90 days are critical,” said Dr. Amir Eissa, Medical Director of BHG Westminster and Centennial.  “During that time we work hard to ensure the patient is responding well to the medication and improving in their lives.  For patients in treatment for 90 days, we have excellent results as measured by almost all objective criteria – abstinence from drug use, improvements in employment, family dynamics and general well-being.”

In Colorado, BHG Treatment Centers are active participants with the State Medicaid program.  The Company is also working to participate with most major medical insurance programs that cover addiction treatment.  The Company’s objective is to improve access to treatment for those struggling with addiction and recognizes that participating with third party payers is an important component of that objective.

View the original article here.

Behavioral Health Group Acquires Two Addiction Treatment Programs in Georgia

Behavioral Health Group, LLC (BHG) announced today the acquisition of two addiction treatment programs in Tifton and Albany, Georgia.

“Opioid addiction continues to ravage communities across the United States,” said Jay Higham, Chief Executive Officer of BHG. “Our Company’s mission is to expand access to evidence-based treatment in underserved markets across the United States.  The addition of Private Clinic Albany and TLC Clinic of Tifton represents an opportunity to partner with a high quality provider of addiction services and to expand access to even more people in Georgia.”

“We are pleased to welcome all the stakeholders of these two treatment centers to BHG,” said Dwight Mussleman, Chief Development Officer of BHG.  “For patients, we expect to improve access to treatment by participating with Georgia Medicaid once we get through the contracting process with the State.  For teammates, we will provide the Company’s full support including sufficient staffing, modern information systems, regulatory compliance and training and access to capital for expanded services.”

“It was important to me to leave my treatment centers in the hands of a company that will provide the resources necessary to support continued growth and development,” said  Jonathan Connell, President of Private Clinic Albany and TLC Clinic of Tifton.  “With any transition like this, patients and employees are nervous about what this means for them.  BHG managed the transaction very professionally and ensured that there were no disruptions to patient care or undue anxiety for staff, both of which were important to me.”

View the original article here.

Behavioral Health Group Acquires Two Addiction Treatment Programs in Virginia

Behavioral Health Group, LLC (BHG) announced today the acquisition of two addiction treatment programs in Chesapeake and Virginia Beach, Virginia.

“Opioid addiction has reached epidemic proportions in the US,” said Jay Higham, Chief Executive Officer of BHG. “We believe addiction is a brain disease and that the most effective approach to therapy is through a comprehensive, individualized treatment plan utilizing medication and intensive counseling.  We are very excited by the opportunity to bring our treatment philosophy to Virginia and the larger mid-Atlantic marketplace.”

“We are pleased to welcome our new colleagues to BHG,” said Dwight Mussleman, Chief Development Officer of BHG.  “A fundamental component of BHG’s strategy is to develop a regional platform whereby BHG can leverage resources to better serve communities and patients. The addition of these two treatment centers is the next step in our national expansion plans.”

The previous owners of the treatment centers are happy that BHG will continue a patient-centric philosophy by offering individuals personalized treatment in accordance with best practices.  “It was important to us to transfer our treatment centers to a company that is focused on quality care and that has a passion and genuine concern for our patients,” stated Judd Mendelson, Chief Executive Offer and partner in Affinity Health Group.  “In addition, BHG made the sales process very easy and we would recommend them to any treatment center owner looking to sell.”

View original article here.

Behavioral Health Group (BHG) Expands Services in Fort Collins, Colorado

Today, Behavioral Health Group, LLC (BHG) announced the expansion of services in its Fort Collins, Colorado treatment center.  Historically, the BHG Fort Collins Medication Unit, located at 2114 Midpoint Drive, Fort Collins, CO 80525, has been a satellite of BHG’s Longmont Treatment Center. However, beginning today, BHG will begin offering patients its full array of opioid addiction services. In addition to medication-assisted treatment, services will include physician exams, admissions, counseling and lab testing.

“We are pleased to be able to expand our services in Fort Collins,” said Jay Higham, Chief Executive Officer of BHG. “Fort Collins is now BHG’s fourth full-service treatment center in Colorado, and we are pleased to be able to serve patients and communities here.”

Tina Beckley, BHG’s Colorado Regional Director, added: “Our full-service opioid treatment program in Fort Collins will serve patients in the northern and rural counties as well as Southern Wyoming.  Our Fort Collins Treatment Center will join our treatment centers in Longmont, Westminster and Denver, Colorado in providing quality and patient-centered care.”

View the original article here.

U.S. Surgeon General Visits Behavioral Health Group Knoxville Treatment Center

KNOXVILLE, Tenn., June 22, 2016 /PRNewswire/ — In an effort to combat the ever growing rates of opioid addiction in America, the U.S. Surgeon General has launched a multi-faceted campaign to help “Turn the Tide” and roll back the devastating toll on families and communities across the country.

Through a combination of educating prescribers about the opioid epidemic and mobilizing them to improve prescribing practices, the U.S. Surgeon General hopes to curb the epidemic of opioid abuse in America in a meaningful way by providing the public with information to protect themselves and their families and shifting the way we view addiction through on-site visits with staff and patients. During his recent visit to Knoxville, U.S. Surgeon General Vivek Murthy met with local provider Behavioral Health Group (BHG) in an effort to further understand the status of treatment services in an area afflicted with some of the highest per-capita rates of opiate addiction in America.

The U.S. Surgeon General first toured the Ailor Intake Center, where he had an opportunity to engage with the staff charged with discerning between a patient who is appropriate for treatment, and one who may need a different level of care. Derek Walsh, Regional Vice President with BHG, elaborated on the entry requirements – “In order to be considered appropriate for treatment, a patient must meet stringent Federal and State requirements, in addition to our assessment of their medical condition and overall stability.” The Tennessee Department of Mental Health and Substance Abuse Services estimates that approximately 70,000 Tennesseans may qualify for outpatient treatment for opiate addiction.

In touring BHG’s Knoxville Citico Treatment Center Medication Room, Nursing Supervisor Haley Green described for the U.S. Surgeon General the practice of perpetually assessing the patient to ensure medical stability: “Every interaction we have with the patient is an opportunity for us to assess the appropriateness of his/her medical care.” Ensuring that each patient is medically stabilized at the lowest possible dose of either methadone or buprenorphine is a critical component of BHG’s focus on safe and effective treatment.

Fielding questions from local media, the U.S. Surgeon General highlighted the need for expanded access to care, and how critical provider education is to ensure that this epidemic can be curtailed. “Addiction is a chronic illness….not a moral failing or a character flaw,” Murthy said. “We have to shift how we think about addiction, because until we do that, it’s going to be hard for us to, ultimately, get treatment for those who need it.”

BHG Regional Vice President Jeremy Wilkerson echoed the Surgeon General’s remarks to local media – “BHG is delivering high quality medical care in the form of Medication Assisted Treatment (MAT), which is the industry recognized “Gold Standard” for the treatment of this disease.”

About Behavioral Health Group

Behavioral Health Group (BHG) is a leading provider of opioid addiction treatment services. BHG utilizes pharmacotherapy (maintenance and detoxification) and behavioral therapy (counseling) to treat both the bio-chemical and psychosocial aspects of addiction. In doing so, BHG offers patients their best opportunity for a successful recovery. With 38 outpatient treatment centers across the Midwest/South/Southeast, BHG provides a critical service to thousands of individuals and their communities across the country. BHG treatment centers are accredited by The Joint Commission.

For media inquiries, contact:
Derek Walsh
214-365-6133

For prospective patients, contact:
BHG Intake Call Center
214-365-6146
www.bhgrecovery.com

To view the original version on PR Newswire, visit: http://www.prnewswire.com/news-releases/us-surgeon-general-visits-behavioral-health-group-knoxville-treatment-center-300288965.html

To view the article on Yahoo Finance, visit: http://finance.yahoo.com/news/u-surgeon-general-visits-behavioral-210100272.html

Behavioral Health Group, LLC Acquires Two Opioid Treatment Programs in South Carolina

Today, Behavioral Health Group, LLC (BHG) announced the acquisition of two addiction treatment programs in Spartanburg and Aiken, South Carolina.

“We are pleased to welcome our new South Carolina colleagues and patients to BHG,” said Jay Higham, Chief Executive Officer of BHG.  “We look to this type of strategic acquisition as a continuation of steps in building BHG relationships with the communities that we serve, while meeting our overall growth plans. South Carolina represents a new market for the Company and complements our acquisitions in North Carolina in August of 2015.”

“A fundamental component of BHG’s strategy when we make an acquisition is to upgrade the infrastructure by bringing modern technology, employee benefits and additional capacity,” said Dwight Mussleman, Chief Development Officer of BHG.  “As these investments are made, patients benefit by receiving individualized treatment including appropriate medication and counseling.”

Brent Brady, owner of the Spartanburg and Aiken treatment centers and a pharmacist, is happy that BHG will continue his philosophy of helping patients with opioid addiction.  “As I began discussions with BHG it was obvious that we share a passion and concern for patients.  BHG’s mission of providing the best evidenced-based treatment for opioid addiction is as important to me as the details of the transaction, which were fair and transparent to me as the owner.”

BHG’s entry into the Carolinas through the acquisition of four treatment centers represents a commitment to expanding in southeastern US markets through additional acquisitions of opioid treatment programs as well as targeted new treatment center openings in the future.

BHG to acquire North Carolina Treatment Centers

Jay Higham, Behavioral Health Group (BHG) Chief Executive Officer, has announced the acquisition of two opioid treatment programs (OTPs) in North Carolina, located in Asheville and Clyde.

“We are delighted to welcome our North Carolina colleagues and patients to the BHG experience of care,” Higham said. “Additionally, we look to this type of strategic acquisition as a logical next step in building the BHG network, while maintaining excellent patient care.”

Dick Trotman, former owner of and new Executive Director for the North Carolina Market, said, “The North Carolina Team is pleased to join the BHG family. We are excited to leverage their systems and industry position to continue to deliver the best quality care possible.”

The facilities will undergo a number of infrastructure and information technology upgrades over the coming weeks. Derek Walsh, Vice President of Operations Administration, is charged with developing and implementing the acquisition plan – “Over the coming weeks, we will be working with Mr. Trotman and his staff to integrate their facilities into the BHG Network.”

Dwight Mussleman, Chief Development Officer, is eager to see BHG expand into a new market – “There are copious amounts of patients to be served in North Carolina and specifically the Asheville metropolitan area. We are proud to add facilities with a strong reputation for quality.”

View the original article here.

Behavioral Health Group Continues to Expand in Colorado

Behavioral Health Group (BHG) today announced their recent acquisition of Comprehensive Addiction Treatment Services in Denver, Colorado. In conjunction, BHG has relocated and merged their Denver Treatment Center to 2222 E. 18th Avenue, Suite C, Denver, CO 80206.

Denver, CO – “This merger and acquisition helps improve the resources available in order to provide “best-in-class” treatment to the patients in Colorado. BHG will continue to make significant investments in the Denver market in order to continue its mission of producing superior patient outcomes,” said Dwight Mussleman, BHG Chief Development Officer.

Jay Higham, BHG Chief Executive Officer, added, “Quality care is our top priority and every contact we have with a patient should leave that person with a sense of Hope, Respect, and Caring. This acquisition allows for BHG to continuously help meet the needs of patients in the Denver area as an addition to our other locations in Longmont and Westminster, Colorado.”

View the original article here.

BHG Receives Approved Education Provider Status

Behavioral Health Group (BHG) receives Approved Education Provider Status

Dallas, Texas – September ##, 2013Michael Cannizzaro, Behavioral Health Group (BHG) Chairman and Chief Executive Officer, announced that BHG has received authorization from NAADAC, the Association for Addiction Professionals, to grant continuing education credits for its learning and development programs to its licensed drug abuse counselors. The NAADAC Approved Education Provider program highlights BHG’s commitment to quality education and dedication to excellence.

 

The NAADAC Approved Education Provider status identifies BHG’s internal learning and development programs as meeting stringent, nationally approved standards of education developed for the drug abuse counseling field. “As a private provider of opioid addiction treatment services, this authorization as a NAADAC Approved Education Provider represents a significant effort by our Learning and Development department to provide high-quality, relevant, and applicable training programs for our staff; and demonstrates our commitment to drive continuous improvement in all we do,” added James Draudt, BHG President and Chief Operating Officer.

 

Chance Spiker, BHG’s Director of Learning and Development, said, “We strive to ensure that our professional staff of licensed addiction counselors are provided consistent, reliable and quality learning experiences that will benefit not only our internal team members, but the patients and communities we serve. This authorization from NAADAC ensures that the continuing education credits provided by BHG to its team members will be accepted toward national credentialing by the National Certification Commission for Addiction Professionals as well as many individual state licensing/credentialing bodies. This is a significant accomplishment for BHG and we are proud to be recognized by NAADAC for our efforts.”

 

BHG expects to begin providing continuing education hours to its team members beginning in October.

 

About Behavioral Health Group

 

Behavioral Health Group (BHG) is a leading provider of opioid addiction treatment services. BHG utilizes pharmacotherapy (maintenance and detoxification) as well as counseling to treat both the bio-chemical and psychosocial aspects of addiction. In doing so, BHG offers patients their best opportunity for a successful recovery. With 30 outpatient treatment centers across the Midwest/South/Southeast, BHG provides a critical service to thousands of individuals and their communities across the country. BHG treatment centers are accredited by The Joint Commission.

 

For more information, phone 214-365-6100, email inquiries@bhgrecovery.com or visit www.bhgrecovery.com.

 

Media Contact: Deborah G. Fliehman 847-276-2808 ext. 224. DebbieF@Creativetechresources.com

BHG Acquires Opioid Treatment Program in Fort Collins, Colorado

Behavioral Health Group (BHG) Acquires Opioid Treatment Program (OTP) in Fort Collins, Colorado

Dallas, Texas – October 8, 2013 – Michael Cannizzaro, Behavioral Health Group (BHG) Chairman and Chief Executive Officer, announced the acquisition of North Colorado Behavioral Health, an opioid treatment program (OTP) located in Fort Collins, Colorado. Mr. Cannizzaro said, “We are pleased to welcome the Fort Collins staff and patients to the BHG experience of care. This strategic acquisition demonstrates our commitment to continually build relationships with the communities that we serve, while meeting our overall growth plans to serve individuals suffering from opioid addiction.”

 

Dwight Mussleman, BHG Chief Development Officer, said, “BHG now owns and operates three treatment centers in Northern Colorado. The addition of Fort Collins brings the total number of facilities in our Company network of opioid treatment programs to 31. James Draudt, BHG President and Chief Operating Officer, added, “There are numerous patients to be served throughout Northern Colorado. We are proud to add this program to our Colorado presence that currently includes centers in Denver and Boulder.”

 

About Behavioral Health Group

 

Behavioral Health Group (BHG) is a leading provider of opioid addiction treatment services. BHG utilizes pharmacotherapy (maintenance and detoxification) as well as counseling to treat both the bio-­‐chemical and psychosocial aspects of addiction. In doing so, BHG offers patients their best opportunity for a successful recovery. With 31 outpatient treatment centers across the Midwest/South/Southeast/West, BHG provides a critical service to thousands of individuals and their communities across the country. BHG treatment centers are accredited by The Joint Commission.

 

For more information, phone 214-­‐365-­‐6100, email inquiries@bhgrecovery.com or visit www.bhgrecovery.com.

 

Media Contact: Deborah G. Fliehman 847-­‐276-­‐2808 ext. 224. DebbieF@Creativetechresources.com

BHG New Medication Option

Behavioral Health Group (BHG) Outpatient Opioid Treatment Centers Offer New Medication Option for Patients

DALLAS, May 8, 2013 — /PRNewswire/ — Michael Cannizzaro, Behavioral Health Group (BHG) Chairman and Chief Executive Officer, announced that BHG treatment centers are now offering both Buprenorphine and Methadone in their medication-assisted treatment programs.

 

Mr. Cannizzaro said, “BHG’s outpatient opioid addiction treatment centers address each patient’s physical opioid addiction with either Methadone or Buprenorphine medications in combination with counseling and skill development. This expanded service offering demonstrates our commitment to helping each individual patient achieve his/her best functional level in the community.”

 

Kelly Clark, MD, BHG Chief Medical Officer, commented, “Since most patients will be clinically appropriate for either Buprenorphine or Methadone medication, the choice of which medication each patient will try will usually be decided by the patient in consultation with his/her physician. Most patients will do well on either medication, while a few will only do well on one or the other. This additional medication option offers a choice for patients, especially those with medical conditions.”

 

BHG’s mission is to achieve positive patient outcomes by using medication-assisted treatment at the lowest possible medication dosage combined with behavioral therapy to control medical and behavioral signs of opioid addiction within an outpatient setting.

 

About Behavioral Health Group

 

Behavioral Health Group (BHG) is a leading provider of opioid addiction treatment services. BHG utilizes pharmacotherapy (maintenance and detoxification) as well as counseling to treat both the bio-chemical and psychosocial aspects of addiction. In doing so, BHG offers patients their best opportunity for a successful recovery. With 29 outpatient treatment centers across the Midwest/South/Southeast, BHG provides a critical service to thousands of individuals and their communities across the country. BHG treatment centers are accredited by The Joint Commission.

 

For more information, phone 214-365-6187, email inquiries@bhgrecovery.com or visit www.bhgrecovery.com.

Behavioral Health Group (BHG) Acquires Three Opioid Treatment Programs in Eastern Kentucky

DALLAS, Jan. 8, 2013 /PRNewswire/ — Michael Cannizzaro, Behavioral Health Group (BHG) Chairman and Chief Executive Officer announced the acquisition of three opioid treatment programs (OTPs) in Eastern Kentucky located in Hazard, Paintsville, and Pikeville.

Mr. Cannizzaro said, “We are pleased to welcome our new Kentucky colleagues and patients to the BHG experience of care.  Additionally, we look to this type of strategic acquisition as a continuation of steps in building BHG relationships with the communities that we serve, while meeting our overall growth plans.”

Lori A. Nation, MD, former owner and partner of the three Kentucky OTPs, said, “I am pleased to join BHG as the Medical Director for the three programs.  The acquisition process with BHG was straightforward and it has been a pleasure working with the BHG leadership team.”

“We are pleased that Dr. Nation has joined our BHG family, and we look forward to her continuing her important work as we expand our presence into the state of Kentucky,” said Dwight Mussleman, BHG Chief Development Officer.  With the addition of Kentucky, BHG now serves patients and communities in eight (8) states.

Jim Draudt, BHG Chief Operating Officer, said, “Over the coming weeks, we will be working with Dr. Nation and each center’s staff to integrate their programs into the BHG network of treatment facilities.”

View the original article here.

BHG CMO Announcement

Behavioral Health Group Announces Appointment of Kelly Clark, MD, MBA as Chief Medical Officer

DALLAS, TX, July 25, 2012 /PRNewswire/ — The Board of Directors of Behavioral Health Group (“BHG” or “the Company”) today announced the appointment of Kelly J. Clark, MD, MBA, as Chief Medical Officer. Dr. Clark joined BHG July 9, 2012.

 

Dr. Clark joins BHG with a wide breadth and depth of both clinical and administrative experience. She has practiced addiction medicine and psychiatry throughout the continuum of care, and taught addiction treatment as a faculty member of the University of Massachusetts. She comes to BHG having most recently worked to integrate medical and behavioral health care management as Medical Director at CDPHP. She serves as President of the Kentucky Society of Addiction Medicine, where she has practiced medicine for several years and served as Medical Director of a number of Opioid Treatment Programs.

 

“I am thrilled to join BHG in the work of providing excellent treatment services to those patients suffering under the epidemic of opioid addiction,” said Clark. “This disease is ravaging individual lives and entire communities across the country. BHG is uniquely situated to bring best practice medication assisted treatment to thousands of patients, and I am excited to work to increase access to evidence-based, physician-directed, team-delivered, high-quality care”.

 

A Phi Beta Kappa graduate of Coe College in Cedar Rapids, Iowa, Kelly holds a Doctor of Medicine degree from the University of Wisconsin, and a Master of Business Administration with Additional Certification in Health Sector Management from the Fuqua School of Business at Duke University. She is currently on the faculty of the Virginia Tech Carillion School of Medicine. Dr. Clark is a Fellow of the American Society of Addiction Medicine, where she serves as a Director, and is a Distinguished Fellow of the American Psychiatric Association.

 

BHG’s Chairman and CEO, Michael N. Cannizzaro, said of the appointment: “The Board is delighted to welcome Kelly to BHG’s executive team as Chief Medical Officer. Her talents and experiences will be invaluable in directing the pharmacotherapy and behavioral therapy aspect of our business as she builds the Medical Directorate of our company.”

 

About Behavioral Health Group

 

Behavioral Health Group (BHG) is a leading provider of opioid addiction treatment services. BHG utilizes pharmacotherapy (maintenance and detoxification) and behavioral therapy (counseling) to treat both the bio-chemical and psycho-social aspects of addiction. In doing so, BHG offers its patients their best shot at successful recovery. With 23 outpatient treatment centers across the midwest/south/southeast, BHG provides a critical service to thousands of individuals and their communities across the country. BHG’s treatment centers are accredited by The Joint Commission.

 

For more information, call (214) 365-6100, email inquiries@bhgrecovery.com, or visit https://bhgrecovery.com.

 

Behavioral Health Group Contact: James F. Draudt, COO

BHG CEO Announcement

Behavioral Health Group Announces Transition of CEO Andrew Love to Advisory Role; Board Appoints Chairman, Mike Cannizzaro, as Chairman and CEO

DALLAS, TX, July 25, 2012 /PRNewswire/ — The Board of Directors of Behavioral Health Group (“BHG” or “the Company”) today announced that Andrew Love has stepped down as Chief Executive Officer and Director and has transitioned to a consulting role with the Company as he pursues a new opportunity. He is succeeded by Michael N. Cannizzaro, BHG’s Chairman.

 

Andy said of his transition: “It was an honor to build and lead BHG from inception to its sale a year ago to the Frontenac Company. I am delighted to continue working together with the leadership team of professionals at BHG and Frontenac, and I am grateful for the support I’ve received from the Board of Directors and our team members over the last six years as we have built BHG into a leader in the field of opioid addiction treatment.”

 

Mr. Love added, “BHG’s growth will undoubtedly accelerate under the outstanding and experienced leadership of Mike Cannizzaro, with whom I have enjoyed working over the last year. I look forward to my continued support of BHG as a co-founder, advisor, and shareholder.”

 

BHG’s Chairman and CEO, Mike Cannizzaro, said: “The Board expresses its gratitude to Andy for his dedicated service to BHG since co-founding the company in 2006, and we thank him for the vision and leadership he brought to the company. We are delighted that we will be able to draw on Andy’s talents and experience through his participation as an advisor to the Company. We wish him every success in his future endeavors.”

 

Mike Cannizzaro, Chairman and CEO, has 36 years of leadership experience in healthcare companies, including Baxter Healthcare, Caremark International, Beltone Electronics, National Nephrology, and Sunrise Medical, to name a few. He was also an operating partner of JW Childs Associates, a leading private equity firm based in Boston.

 

About Behavioral Health Group

 

Behavioral Health Group (BHG) is a leading provider of opioid addiction treatment services. BHG utilizes pharmacotherapy (maintenance and detoxification) and behavioral therapy (counseling) to treat both the bio-chemical and psycho-social aspects of addiction. In doing so, BHG offers its patients their best shot at successful recovery. With 23 outpatient treatment centers across the midwest/south/southeast, BHG provides a critical service to thousands of individuals and their communities across the country. BHG’s treatment centers are accredited by The Joint Commission.

 

For more information, call (214) 365-6100, email inquiries@bhgrecovery.com, or visit https://bhgrecovery.com.

 

Behavioral Health Group Contact: James F. Draudt

BHG Tennessee Announcement

Behavioral Health Group (BHG) Acquires Opioid Treatment Program in Tennessee

Dallas, Texas – May 7, 2013 – Michael Cannizzaro, Behavioral Health Group (BHG) Chairman and Chief Executive Officer, announced the acquisition of an opioid treatment program (OTP) in Central Tennessee located in Columbia. “We are pleased to welcome the Columbia staff and patients to the BHG experience of care. This strategic acquisition demonstrates our commitment to continually build relationships with the communities that we serve, while meeting our overall growth plans to serve individuals suffering from opioid addiction.”

 

Dwight Mussleman, BHG Chief Development Officer, said, “There are numerous patients to be served throughout Central Tennessee. We are proud to add this program to our Tennessee presence that currently includes centers in Jackson, Knoxville, Memphis, Nashville and Paris.”

 

Denise Woodie, Program Director, said, “Our treatment center staff is excited to be a part of the BHG family. We have enjoyed working with the BHG executive team through this transition and found this integration process to be smooth and uncomplicated. Becoming part of the BHG network of treatment centers allows us to leverage both the organization’s resources and knowledge to deliver excellent patient care and enhanced support to ensure that our patients progress efficiently through their recovery process.”

 

About Behavioral Health Group

 

Behavioral Health Group (BHG) is a leading provider of opioid addiction treatment services. BHG utilizes pharmacotherapy (maintenance and detoxification) as well as counseling to treat both the bio-chemical and psychosocial aspects of addiction. In doing so, BHG offers patients their best opportunity for a successful recovery. With 29 outpatient treatment centers across the Midwest/South/Southeast, BHG provides a critical service to thousands of individuals and their communities across the country. BHG treatment centers are accredited by The Joint Commission.

 

For more information, phone 214-365-6100, email inquiries@bhgrecovery.com or visit www.bhgrecovery.com.

 

Media Contact: Deborah G. Fliehman 847-276-2808 ext. 224. DebbieF@Creativetechresources.com